NanoLogix, Inc. a
nano-biotechnology company announces that the company has submitted
international patent applications for BioNanoChannel(TM) and Hydrogen
Bioreactor technology protection for China, India, Brazil, and the EU
(European Union). These filings are necessary prior to the anticipated
global roll-out of the company's BioNanoChannel(TM) rapid
bacteria/microorganism detection technology and also contribute to the
protection of NanoLogix's ongoing Hydrogen Bioreactor development.
Chris Novak, NanoLogix Director of IP stated: "The strength
and improved focus of the new foreign cases arose from significant
improvements to the originally filed provisional patent applications.
We at NanoLogix are very excited about the potential for enhancing the
patent protection for these new technologies."
According to Bret Barnhizer, NanoLogix President and CEO,
"This is a step forward for the company in its plans for technological
and business development and sets the stage for one of our corporate
goals of pursuing licensing opportunities for use of our products
internationally. These applications aid us by ensuring that NanoLogix
strengthens their control over the intellectual property rights to the